For over a century, there has been intense debate as to the reason why some cardiac stresses are pathological and others are physiological. One long-standing theory is that physiological overloads such as exercise are intermittent, while pathological overloads such as hypertension are chronic. In this study, we hypothesized that the nature of the stress on the heart, rather than its duration, is the key determinant of the maladaptive phenotype. To test this, we applied intermittent pressure overload on the hearts of mice and tested the roles of duration and nature of the stress on the development of cardiac failure. Despite a mild hypertrophic response, preserved systolic function, and a favorable fetal gene expression profile, hearts exposed to intermittent pressure overload displayed pathological features. Importantly, intermittent pressure overload caused diastolic dysfunction, altered β-adrenergic receptor (βAR) function, and vascular rarefaction before the development of cardiac hypertrophy, which were largely normalized by preventing the recruitment of PI3K by βAR kinase 1 to ligand-activated receptors. Thus stress-induced activation of pathogenic signaling pathways, not the duration of stress or the hypertrophic growth per se, is the molecular trigger of cardiac dysfunction.
Cinzia Perrino, Sathyamangla V. Naga Prasad, Lan Mao, Takahisa Noma, Zhen Yan, Hyung-Suk Kim, Oliver Smithies, Howard A. Rockman
Title and authors | Publication | Year |
---|---|---|
T cell costimulation blockade blunts pressure overload-induced heart failure
M Kallikourdis, E Martini, P Carullo, C Sardi, G Roselli, CM Greco, D Vignali, F Riva, AM Berre, TO Stølen, A Fumero, G Faggian, ED Pasquale, L Elia, C Rumio, D Catalucci, R Papait, G Condorelli |
Nature Communications | 2017 |
Murine Models of Heart Failure With Preserved Ejection Fraction
M Valero-Muñoz, W Backman, F Sam |
JACC: Basic to Translational Science | 2017 |
Short-Term Administration of Serelaxin Produces Predominantly Vascular Benefits in the Angiotensin II/L-NAME Chronic Heart Failure Model
JC McCarthy, M Aronovitz, JJ DuPont, TD Calamaras, IZ Jaffe, RM Blanton |
JACC: Basic to Translational Science | 2017 |
Molecular Mechanisms Underlying Cardiac Adaptation to Exercise
RB Vega, JP Konhilas, DP Kelly, LA Leinwand |
Cell Metabolism | 2017 |
Size matters: Finding growth pathways that protect the heart
JS Guseh, A Rosenzweig |
Cell Research | 2017 |
Cardiac damage in athlete’s heart: When the “supernormal” heart fails!
A Carbone, A DAndrea, L Riegler, R Scarafile, E Pezzullo, F Martone, R America, B Liccardo, M Galderisi, E Bossone, R Calabrò |
World journal of cardiology | 2017 |
Beneficial Effects of Paeoniflorin Enriched Extract on Blood Pressure Variability and Target Organ Damage in Spontaneously Hypertensive Rats
B Li, ZB Yang, SS Lei, J Su, MX Pang, C Yin, GY Chen, CW Shan, B Chen, HM Hu, SH Chen, GY Lv |
Evidence-Based Complementary and Alternative Medicine | 2017 |
β‐Adrenergic Stimulation Induces Histone Deacetylase 5 (HDAC5) Nuclear Accumulation in Cardiomyocytes by B55α‐PP2A‐Mediated Dephosphorylation
KL Weeks, A Ranieri, A Karaś, BC Bernardo, AS Ashcroft, C Molenaar, JR McMullen, M Avkiran |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2017 |